The elusive magic pill: finding effective therapies for mitochondrial disorders.
The incidence of mitochondrial diseases has been estimated at 11.5/100,000 (1:8500) worldwide. In the USA up to 4000 newborns annually are expected to develop a mitochondrial disease. More than 50 million adults in the USA also suffer from diseases in which primary or secondary mitochondrial dysfunction is involved. Mitochondrial dysfunction has been identified in cancer, infertility, diabetes, heart diseases, blindness, deafness, kidney disease, liver disease, stroke, migraine, dwarfism, and resulting from numerous medication toxicities. Mitochondrial dysfunction is also involved in normal aging and age-related neurodegenerative diseases, such as Parkinson and Alzheimer diseases. Yet most treatments available are based on empiric data and clinician experience because of the lack of randomized controlled clinical trials to provide evidence-based treatments for these disorders. Here we explore the current state of research for the treatment of mitochondrial disorders.
Division of Child Neurology, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA 20892, USA.
Amy
A
Goldstein
Lynne A
LA
Wolfe
D000975:Antioxidants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003067:Coenzymes / Q000627:therapeutic use; D004272:DNA, Mitochondrial / Q000235:genetics; D006801:Humans; D028361:Mitochondrial Diseases / Q000178:diet therapy / Q000188:drug therapy* / Q000235:genetics
D000975:Antioxidants; D003067:Coenzymes; D004272:DNA, Mitochondrial